Last reviewed · How we verify

NCT05020171: Lambda_MIpil

Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients

Terminated NA Last updated 3 May 2024
What this trial tests

NA trial testing Group of strength training in Stroke in 5 participants. Terminated before completion.

Timeline
20 September 2021
Primary endpoint
29 January 2024
29 January 2024

Quick facts

Lead sponsorInstitution de Lavigny
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment5
Start date20 September 2021
Primary completion29 January 2024
Estimated completion29 January 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Institution de Lavigny

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The loss of lower limb strength that occurs after an Acquired Brain Injury (ABI) limits the patient's autonomy in participating in activities of daily living, including gait performance. In the sub-acute phase, it is difficult to implement a strengthening program, as weakness prevents exercise being performed with the recommended parameters. This limit can be exceeded by using specific robotic devices, which allow the effort provided to be adapted according to the patient's capacities. In addition, motivation can be improved by the use of feedback or incentive games. The aim of this pilot study is to obtain data on the effect of lower limb strength training with a seated robotic device in subacute ABI patients for a future larger randomised study. In addition, it aims to evaluate the recruitment rate, applicability, resources for implementation and patient tolerance to the training program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05020171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing